Home
About
Overview
Sharing Data
ORCID
Help
History (34)
Proteomic Profiling of Hsp90 Inhibitors.
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
Association of Hsp90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function.
Retinoid processing in cone and Müller cell lines.
Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist.
See All 34 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist.
Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist. J Cardiovasc Electrophysiol. 2008 Aug; 19(8):861-8.
View in:
PubMed
subject areas
Animals
Anti-Arrhythmia Agents
Atracurium
Atrial Fibrillation
Dogs
Dose-Response Relationship, Drug
Heart Atria
Heart Rate
Injections, Intravenous
Male
Neuromuscular Blocking Agents
Receptor, Muscarinic M2
authors with profiles
Benjamin J Scherlag
Sunny S Po
Warren M Jackman